MilliporeSigma invests in new life science site in South Korea

BURLINGTON - MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, invests more than €300 million into a new Bioprocessing Production Center in Daejeon, South Korea.

Related Keywords

Germany ,Canada ,China ,Burlington ,Newfoundland ,United States ,South Korea ,Daejeon ,Taejon Gwangyoksi ,Matthias Heinzel ,Songdo Incheon ,Merck Kga ,Collaboration Center ,Dm Lab ,Merck Kgaa ,Bioprocessing Production Center ,Canada Life Science ,Life Science ,Executive Board ,The Economy ,Rade ,Medicine ,Harmacology ,Iology ,Industry ,Business ,Ob Market ,Iochemistry ,Enetics ,